How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Context graphs, graph memory, and ontologies for AI are converging. What does this mean for enterprise AI in 2026?

The ordinary graphite in pencil lead is proving to be surprisingly multifaceted at the microscale. In a study published in ...